VACCINE

Dec 28 2024HEALTH

HPV Vaccine and Screening in Japan: A Cost-Effective Solution?

In Japan, only about three out of ten women get vaccinated against the human papillomavirus (HPV), and just four out of ten get regular cervical screenings. That's why the Japanese Government is trying to boost these numbers. Let's dive into whether using the 9-valent HPV vaccine along with regular

reading time less than a minute
Dec 28 2024HEALTH

How Different News Sources Talked About COVID Vaccines

When the COVID-19 vaccines were first announced, they sparked a lot of debate. Most studies focused on misinformation on social media, but not much was said about how mainstream and alternative news sources talked about the vaccines. To fill this gap, researchers used cognitive network science and n

reading time less than a minute
Dec 27 2024HEALTH

The Power of Pediatric Flu Vaccines: A Look at Their Effectiveness from 2015-2020

From 2015 to 2020, researchers have been keeping a close eye on how well flu vaccines protect kids from severe influenza. The goal? To boost vaccine use and make sure policies around the world are solid. Kids can get hit hard by the flu, and severe cases can lead to hospital visits or even worse. S

reading time less than a minute
Dec 27 2024HEALTH

Parents' Views on Vaccinating Girls Against HPV in Jimma Town

Human Papillomavirus, or HPV, is a common virus spread through sexual contact, and it's a major cause of cervical cancer. In Ethiopia, HPV is quite common, but not many people are getting the HPV vaccine. This study looked into how many parents in Jimma Town are willing to vaccinate their daughters

reading time less than a minute
Dec 27 2024HEALTH

COVID-19 Vaccine Uptake Among Disabled Kenyans: What Matters Most?

Let's talk about vaccines and why some disabled people in Kenya aren't getting their COVID-19 shots. A study found that 59% of disabled folks were fully vaccinated, but those with mental or self-care issues were left behind. What makes someone decide to get vaccinated? Trust in the benefits, doctor'

reading time less than a minute
Dec 26 2024HEALTH

Vaccine Clinical Trials: Boosting Capabilities in Nepal

Clinical trials are a big deal when it comes to checking if new vaccines or medicines are safe and work as they should. These trials are tricky and take a lot of time. They need the help of government officials, trial sites, researchers, and the whole health system. In recent years, many of these tr

reading time less than a minute
Dec 26 2024HEALTH

Setting Fair Prices for COVID-19 Vaccines: A Math-Based Approach

You might think setting the price for COVID-19 vaccines is simple. But it's not. The World Health Organization (WHO) wants these vaccines to be like a global public good – available and affordable to everyone. That's a tall order, especially with two big players, Pfizer and Moderna, in the U. S. mar

reading time less than a minute
Dec 26 2024HEALTH

What’s the Deal with COVID Vaccines in Pima County’s Hispanic Community?

Throughout the COVID-19 pandemic, there’s been a noticeable hesitancy among marginalized populations, especially within the Hispanic community in Pima County, Arizona, when it comes to taking the vaccine. A recent study took a close look at how political views impact the decision-making process of H

reading time less than a minute
Dec 22 2024HEALTH

Vaccine Fairness: Seeing the Whole Picture in Ethiopia

Fair access to COVID-19 vaccines is crucial, but we don't know much about the situation in Ethiopia. A recent study aims to change that by exploring how different social and geographical factors influence vaccine uptake there. Let's zoom in on what's happening. In Ethiopia, it's not just about havi

reading time less than a minute
Dec 22 2024HEALTH

Vaccine Approval in Brazil: Leveraging Expertise and Navigating Politics

The COVID-19 pandemic exposed the crucial role of a country's regulatory abilities. Nations had to fast-track new vaccine technologies amidst scientific uncertainty and political pressure, a particularly tough challenge for middle-income countries with less experience in crisis regulation. How did c

reading time less than a minute